These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36967448)

  • 1. Prospective, Observational, Multicenter, Real-World Study of the Efficacy, Safety, and Pattern of Use of the Dexamethasone Intravitreal Implant in Diabetic Macular Edema in France: Short-Term Outcomes of LOUVRE 3.
    Kodjikian L; Delcourt C; Creuzot-Garcher C; Massin P; Conrath J; Velard MÈ; Lassalle T; Pinchinat S; Dupont-Benjamin L
    Ophthalmol Ther; 2023 Jun; 12(3):1671-1692. PubMed ID: 36967448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-Life Efficacy, Safety, and Use of Dexamethasone Intravitreal Implant in Posterior Segment Inflammation Due to Non-infectious Uveitis (LOUVRE 2 Study).
    Bodaghi B; Brézin AP; Weber M; Delcourt C; Kodjikian L; Provost A; Velard MÈ; Barnier-Ripet D; Pinchinat S; Dupont-Benjamin L
    Ophthalmol Ther; 2022 Oct; 11(5):1775-1792. PubMed ID: 35802252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
    Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study.
    Augustin AJ; Kuppermann BD; Lanzetta P; Loewenstein A; Li XY; Cui H; Hashad Y; Whitcup SM;
    BMC Ophthalmol; 2015 Oct; 15():150. PubMed ID: 26519345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial.
    Eter N; Mohr A; Wachtlin J; Feltgen N; Shirlaw A; Leaback R;
    Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):77-87. PubMed ID: 27460280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone intravitreal implant in treatment-naïve diabetic macular oedema: findings from the prospective, multicentre, AUSSIEDEX study.
    Fraser-Bell S; Kang HK; Mitchell P; Arnold JJ; Tainton J; Simonyi S
    Br J Ophthalmol; 2023 Jan; 107(1):72-78. PubMed ID: 34433549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-Term Outcomes of Refractory Diabetic Macular Edema Switch From Ranibizumab to Dexamethasone Implant and the Influential Factors: A Retrospective Real World Experience.
    Hsia NY; Lin CJ; Chen HS; Chang CH; Bair H; Lai CT; Lin JM; Chen WL; Tien PT; Wu WC; Tsai YY
    Front Med (Lausanne); 2021; 8():649979. PubMed ID: 33996856
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of Diabetic Macular Edema with Multiple Dexamethasone Intravitreal Implants: Evidence from Real-Life Experience.
    De Geronimo D; Giorno P; Scarinci F; Boninfante A; Varano M; Parravano M
    Ophthalmologica; 2020; 243(6):413-419. PubMed ID: 31760387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone intravitreal implant in diabetic macular oedema refractory to anti-vascular endothelial growth factors: the AUSSIEDEX study.
    Mitchell P; Arnold J; Fraser-Bell S; Kang HK; Chang AA; Tainton J; Simonyi S
    BMJ Open Ophthalmol; 2023 Aug; 8(1):. PubMed ID: 37541745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.
    Boyer DS; Yoon YH; Belfort R; Bandello F; Maturi RK; Augustin AJ; Li XY; Cui H; Hashad Y; Whitcup SM;
    Ophthalmology; 2014 Oct; 121(10):1904-14. PubMed ID: 24907062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of a Dexamethasone Implant in Patients with Diabetic Macular Edema at Tertiary Centers in Korea.
    Moon BG; Lee JY; Yu HG; Song JH; Park YH; Kim HW; Ji YS; Chang W; Lee JE; Oh J; Chung I
    J Ophthalmol; 2016; 2016():9810270. PubMed ID: 27293879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmarketing safety surveillance of dexamethasone intravitreal implant in the treatment of visual impairment due to diabetic macular edema in India.
    Nair U; Gupta V; Sharma M; Joshi S; Sudhalkar A; Altangerel U; Bai Y;
    BMC Ophthalmol; 2020 Oct; 20(1):405. PubMed ID: 33036583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-World Assessment of Dexamethasone Intravitreal Implant in DME: Findings of the Prospective, Multicenter REINFORCE Study.
    Singer MA; Dugel PU; Fine HF; Capone A; Maltman J
    Ophthalmic Surg Lasers Imaging Retina; 2018 Jun; 49(6):425-435. PubMed ID: 29927470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of diabetic macular edema treated with dexamethasone implant: a real-life study.
    Mathis T; Lereuil T; Abukashabah A; Voirin N; Sudhalkar A; Bilgic A; Denis P; Dot C; Kodjikian L
    Acta Diabetol; 2020 Dec; 57(12):1413-1421. PubMed ID: 32656710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.
    Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Loewenstein A; Yoon YH; Jiao J; Li XY; Whitcup SM; ; Li J
    Ophthalmology; 2011 Dec; 118(12):2453-60. PubMed ID: 21764136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience.
    Blanc J; Deschasse C; Kodjikian L; Dot C; Bron AM; Creuzot-Garcher C
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1441-1448. PubMed ID: 29855706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study.
    Lam WC; Albiani DA; Yoganathan P; Chen JC; Kherani A; Maberley DA; Oliver A; Rabinovitch T; Sheidow TG; Tourville E; Wittenberg LA; Sigouin C; Baptiste DC
    Clin Ophthalmol; 2015; 9():1255-68. PubMed ID: 26203215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Reinjection Numbers and Intervals for Diabetic Macular Edema Patients Who Received Dexamethasone Intravitreal Implants in Germany and Switzerland.
    Augustin AJ; Becker MD; Hatz K; Kaymak H; Shirlaw A
    Clin Ophthalmol; 2021; 15():3957-3967. PubMed ID: 34616140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone Intravitreal Implant for the Treatment of Macular Edema Following Retinal Vein Occlusion: Post Hoc Analysis of Post-Marketing Surveillance Data in the Real-World Setting in Korea.
    Kim MS; Choi J; Lee HD; Woo SJ;
    Clin Ophthalmol; 2021; 15():3623-3636. PubMed ID: 34475750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.